Sunday, April 11, 2021

FDA authorizes Johnson & Johnson coronavirus vaccine

FDA authorizes Johnson & Johnson coronavirus vaccine

State and local health officials have also expressed optimism about the incoming vaccine.

“I’m already looking forward to the Johnson & Johnson vaccine and I would love to have information — what temperature does it need to be stored at … how many doses of each of each vaccine is going to be contained in these vials — so I could already start planning for it,” Rais Vohra, interim health officer for Fresno County, Calif., told POLITICO earlier this month.

An advisory panel to the Centers for Disease Control and Prevention will meet Sunday to consider and vote on recommendations on who should receive the J&J shot. That’s the final step before the vaccine can be used for the general public.

The panel may address some remaining questions about how well the vaccine works in older people with some common health problems. Limited J&J data from this group indicates the shot is just 42 percent effective among people 60 and older with common risk factors, like diabetes, heart problems and obesity.

However, FDA and the company on Friday said additional data may ultimately prove the shot is more effective in this group.

Source link

Leave a Response